Healthcare Triangle HCTI
- Market cap
- $5M
- PE
- n/m
- one or more of the four quarters through 2026-06-30 missing
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- n/m
- one or more of the four quarters through 2026-06-30 missing
- EV/EBIT
- n/m
- not a meaningful number
- Revenue, 12 months
- n/m
- one or more of the four quarters through 2026-06-30 missing
- Net margin
- n/m
- one or more of the four quarters through 2026-06-30 missing
- Free cash flow yield
- n/m
- not a meaningful number
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $7.8M−35% | $7.1M−38% | $4.1M−58% | $3M−65% | $2.4M−69% | n/a | $3.7M−10% | $3.6M+19% | $3.5M+45% | n/a | $9.9M+166% | $9.2M+158% | |
| Cost of revenue | $6.1M−29% | $5.5M−42% | $3.1M−63% | $2.1M−68% | $1.7M−72% | n/a | $3.4M+9% | $3.1M+47% | $2.9M+70% | n/a | $7.5M+121% | $7.1M+133% |
| Gross profit | $1.7M−50% | $1.5M−16% | $1M−36% | $898K−54% | $722K−58% | n/a | $329K−68% | $494K−45% | $618K−14% | n/a | $2.4M+627% | $2.1M+318% |
| R&D | $54K−96% | $104K−96% | $127K−76% | $207K+103% | $175K+224% | n/a | $144K+13% | $55K−73% | $59K−66% | n/a | $85K−41% | $51K−7% |
| SG&A | $2.5M−25% | $1.6M−45% | $2.1M−39% | $1.5M−42% | $1.4M−44% | n/a | $1.6M−24% | $1.8M+17% | $3.1M+127% | n/a | $5M+218% | $5.5M+208% |
| −$1.5M−32% | −$5M+1% | −$1.7M−47% | −$1.4M−14% | −$1.2M−23% | n/a | −$1.4M−18% | −$1.4M−1% | −$2.6M+122% | n/a | −$3.6M+159% | −$4.1M+200% | |
| Interest expense | $415K+655% | $305K+268% | $149K+140% | $131K−30% | $80K−81% | $853K+180% | $316K+112% | $0 | $151K+89% | n/a | $89K−72% | $84K |
| Pre-tax income | −$1.9M−16% | −$5.3M+10% | −$1.9M−43% | −$1.5M−15% | −$1.2M−36% | n/a | −$1.7M−9% | −$1.4M−9% | −$1.9M+53% | n/a | −$6.2M+265% | −$4.4M+221% |
| $4K−89% | $7K−42% | $5K−74% | $1K−80% | $2K−50% | n/a | n/a | n/a | n/a | n/a | n/a | $24K | |
| Net income | −$1.9M−17% | −$5.3M+10% | −$1.9M−43% | −$1.5M−16% | −$1.2M−36% | −$1.3M−75% | −$1.7M−9% | −$1.4M−10% | −$1.9M+53% | −$4.5M+234% | −$6.2M+265% | −$4.4M+223% |
| −$6723.00−25% | −$19123.20 | −$6274.80−47% | −$4243.20−32% | −$3286.80−51% | −$27919.80+46% | −$2539.80−60% | −$35.01−99% | −$25.20−99% | n/a | −$6.81−100% | −$1.56−96% | |
| 286+19% | 266 | 298+7% | 356+24% | 379+33% | 379+42% | 659+121% | 39.1K+10876% | 74.1K+19428% | n/a | 930.7K+141125% | 2.8M+7083% |
Gross profit: 21 periods, Q3 FY20 to Q1 FY26: not printed by the filing, worked out from its own lines.
EPS, diluted: 8 periods, Q4 FY20 to Q4 FY24: quarter's net income to common over its shares, to the cent.
Diluted shares: Q4 FY20 and Q4 FY23: share-days: the 12-month average less the 9-month, weighted by days. Q4 FY21 and Q4 FY24: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Software - Infrastructure nearest Healthcare Triangle's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| HCTIHealthcare Triangle | $5M | n/m | n/a | n/m | n/m | n/m | |
| MSGMMotorsport Games | $22.5M | 11.4× | 11.5× | 1.5× | +79% | 16.2% | |
| FIEEFiEE | $26.9M | 9.3× | 102× | n/m | n/m | n/m | |
| IDNIntellicheck | $49.5M | 16.3× | 39.8× | 2.1× | +17% | 13.0% | |
| Peer median | $26.9M | 11.4× | 39.8× | 1.8× | +48% | 14.6% |
More on Healthcare Triangle
Each number over time
- PE ratio
- Price to sales ratio
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Its groups
About
- Industry
- Software - Infrastructure
- Sector
- Technology
Valuation data, not investment advice. Prices as of .